Search This Blog

Thursday, February 13, 2020

Agios Pharmaceuticals EPS beats by $0.08, beats on revenue

Agios Pharmaceuticals (NASDAQ:AGIO): Q4 GAAP EPS of -$1.60 beats by $0.08.
Revenue of $35.44M (+18.1% Y/Y) beats by $1.72M.
Press Release
https://seekingalpha.com/news/3541609-agios-pharmaceuticals-eps-beats-0_08-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)